-
公开(公告)号:EP0687265B1
公开(公告)日:2002-01-23
申请号:EP94908992.4
申请日:1994-03-04
申请人: NOVO NORDISK A/S
IPC分类号: C07D417/14 , C07D417/04 , C07D413/14 , C07D413/04 , A61K31/41 , A61K31/44
CPC分类号: C07D413/04 , C07D417/04 , C07D417/14 , Y10S514/913
摘要: The present invention relates to therapeutically active azabicyclic compounds of Formula (1), wherein Z1 is oxygen or sulphur; a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
摘要翻译: 本发明涉及式(1)的治疗活性氮杂双环化合物,其中Z 1是氧或硫; 其制备方法和包含该化合物的药物组合物。 这些新型化合物可用作哺乳动物前脑和海马认知功能的兴奋剂,特别是用于治疗阿尔茨海默病,严重疼痛和青光眼。
-
公开(公告)号:EP1171438A1
公开(公告)日:2002-01-16
申请号:EP00918726.1
申请日:2000-04-17
申请人: NOVO NORDISK A/S
IPC分类号: C07D471/04 , C07D223/22 , A61K31/437 , A61K31/55 , A61P3/10 , A61P3/04
CPC分类号: C07D471/04 , C07D223/22
摘要: The present invention relates to compounds of general formula (I). The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR).
-
公开(公告)号:EP0910566A1
公开(公告)日:1999-04-28
申请号:EP97917287.0
申请日:1997-04-11
申请人: NOVO NORDISK A/S
发明人: OLESEN, Preben, H. , SAUERBERG, Per
CPC分类号: C07D417/04 , C07D471/08
摘要: The present invention relates to therapeutically active azacyclic or azabicyclic compounds with formula (I), wherein X is oxygen or sulfur and wherein G is selected from the group of azacyclic or azabicyclic ring systems consisting of formula (A), a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating a cholinergic deficit in the peripheral system.
-
公开(公告)号:EP0888355A1
公开(公告)日:1999-01-07
申请号:EP97914172.0
申请日:1997-03-19
申请人: NOVO NORDISK A/S
发明人: JEPPESEN, Lone , SAUERBERG, Per
CPC分类号: C07D487/08
摘要: The present invention relates to therapeutically active azabicyclic compounds of formula (I) or the quaternized form thereof, a method of preparing the same and to pharmaceutical or veterinary compositions comprising the compounds. The novel compounds are useful in treating a disease in the central nervous system caused by malfunctioning of the muscarinic cholinergic system.
-
公开(公告)号:EP0544779B1
公开(公告)日:1998-12-02
申请号:EP91915629.9
申请日:1991-08-20
申请人: NOVO NORDISK A/S
发明人: SAUERBERG, Per , OLESEN, Preben, H.
IPC分类号: C07D453/02 , C07D471/18 , C07D487/08 , A61K31/395
CPC分类号: C07D471/08 , C07D451/02 , C07D453/02 , C07D487/08
摘要: The present invention relates to therapeutically active piperidine compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds of formula (I), wherein X is oxygen or sulphur; wherein G is selected from the group of azabicyclic ring systems consisting of (1), (2), or (3) wherein the oxadiazole or thiadiazole ring can be attached at any position. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
-
公开(公告)号:EP0793665A1
公开(公告)日:1997-09-10
申请号:EP95938361.0
申请日:1995-11-20
申请人: NOVO NORDISK A/S
CPC分类号: C07D513/04 , C07D513/14
摘要: The present invention relates to therapeutically active azacyclic or azabicyclic compounds of formula (I), wherein X is -C-, -O-, -S-, =C- or -N(R3)-, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating diseases in the central nervous system caused by malfunctioning of the muscarinic cholinergic system.
-
公开(公告)号:EP0687266A1
公开(公告)日:1995-12-20
申请号:EP94908990.0
申请日:1994-03-04
申请人: NOVO NORDISK A/S
发明人: SAUERBERG, Per , OLESEN, Preben, H.
CPC分类号: C07D451/02 , C07D451/04 , C07D453/02 , C07D471/08 , C07D487/08
摘要: The present invention relates to therapeutically active azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions of glaucoma. The novel compounds of the invention are heterocyclic compounds having formula (I) wherein X is oxygen or sulphur; G is selected from one of the following azabicyclic rings (II) or (III) wherein the thiadiazole or oxadiazole ring can be attached at any carbon atom of the azabicyclic ring; R?1 and R2¿ may be present at any position, including the point of attachment of the thiadiazole or oxadiazole ring.
摘要翻译: 本发明涉及治疗活性氮杂双环化合物,其制备方法以及包含该化合物的药物组合物。 这些新型化合物可用作哺乳动物前脑和海马认知功能的兴奋剂,特别是治疗阿尔茨海默氏病,青光眼的严重疼痛病症。 本发明的新化合物是具有式(I)的杂环化合物,其中X是氧或硫; G选自下列氮杂双环(II)或(III)之一:其中噻二唑或恶二唑环可以连接在氮杂双环的任何碳原子上; R 1和R 2'可以存在于任何位置,包括噻二唑或恶二唑环的连接点。
-
公开(公告)号:EP0544714B1
公开(公告)日:1995-11-22
申请号:EP91914368.5
申请日:1991-08-20
申请人: NOVO NORDISK A/S
IPC分类号: C07D417/04 , C07D417/14 , C07D413/04 , C07D413/14 , A61K31/44
CPC分类号: C07D413/04 , C07D417/04
摘要: The present invention relates to therapeutically active azacyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
-
公开(公告)号:EP0544714A1
公开(公告)日:1993-06-09
申请号:EP91914368.0
申请日:1991-08-20
申请人: NOVO NORDISK A/S
CPC分类号: C07D413/04 , C07D417/04
摘要: La présente invention se rapporte à des procédés azacycliques thérapeutiquement actifs, à un procédé de préparation de ceux-ci et à des compositions pharmaceutiques comprenant lesdits composés. Les nouveaux composés sont utiles comme stimulants de la fonction cognitive du cerveau antérieur et de l'hippocampe des mammifères et, en particulier, pour le traitement de la maladie d'Alzheimer, des états douloureux aigus et du glaucome.
摘要翻译: 本发明涉及治疗活性氮杂环方法,其制备方法和包含所述化合物的药物组合物。 该新型化合物可用作哺乳动物前脑和海马认知功能的兴奋剂,特别是用于治疗阿尔茨海默病,急性疼痛状态和青光眼。
-
60.
公开(公告)号:EP3730127A1
公开(公告)日:2020-10-28
申请号:EP20160668.8
申请日:2011-12-16
申请人: Novo Nordisk A/S
IPC分类号: A61K9/20 , A61K38/26 , A61P3/04 , A61P3/10 , A61K45/06 , A61K31/195 , A61P1/04 , A61P3/00 , A61P3/06 , A61P9/00 , A61P15/08 , A61P25/28 , A61P43/00
摘要: The present invention relates to solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and their use in medicine.
-
-
-
-
-
-
-
-
-